backgroundrespiratori
infect
lead
caus
pediatr
hospit
studi
investig
whether
virusviru
virusbordetella
coinfect
frequent
sever
previous
recogn
methodsthi
prospect
studi
children
younger
month
hospit
febril
respiratori
ill
viral
pathogen
detect
use
multiplex
polymeras
chain
reaction
pcr
enzymelink
immunoassay
andor
viral
cultur
nasopharyng
sampl
bordetella
infect
detect
pcr
resultsa
total
patient
enrol
respiratori
virus
detect
patient
multipathogen
infect
common
virus
detect
respiratori
syncyti
viru
rhinovirusenteroviru
differ
ill
sever
compar
patient
infect
one
pathogen
multipathogen
infect
conclusionviru
coinfect
young
children
hospit
acut
febril
respiratori
infect
common
appear
associ
ill
sever
approxim
children
hospit
unit
state
year
clinic
diagnosi
viral
lower
respiratori
tract
infect
lrti
histor
half
patient
ever
viral
etiolog
identifi
caus
ill
wherea
respiratori
syncyti
viru
rsv
account
major
hospit
human
metapneumoviru
hmpv
parainfluenza
virus
piv
rhinovirus
enterovirus
adenovirus
influenza
virus
also
result
moder
sever
infect
requir
hospit
virus
infect
lower
respiratori
tract
often
caus
bronchiol
andor
pneumonia
less
typic
find
may
also
develop
includ
period
breath
apnea
particularli
young
infant
young
children
infect
bordetella
pertussi
b
parapertussi
bacteri
caus
classic
pertussi
syndrom
share
overlap
featur
viral
lrti
least
viru
group
rsv
adenoviru
known
caus
pertussi
syndrom
recent
studi
shown
simultan
infect
one
viru
pathogen
occur
children
diagnos
bronchiol
rsv
influenza
rhinoviru
adenoviru
hmpv
common
infect
agent
two
studi
one
rel
recent
also
document
rate
coinfect
rsv
b
pertussi
approxim
howev
studi
attempt
correl
dual
infect
ill
sever
limit
yield
conflict
result
histor
standard
cell
cultur
gold
standard
laboratori
detect
respiratori
virus
method
technic
challeng
sever
day
requir
result
avail
moreov
sever
common
etiolog
agent
easili
cultur
use
standard
techniqu
rapid
immunoassay
antigen
detect
test
routin
avail
detect
rsv
influenza
known
suboptim
sensit
contrast
detect
viral
antigen
respiratori
secret
immunofluoresc
greater
sensit
labor
intens
highli
depend
experi
skill
observ
recent
emerg
pcr
base
technolog
substanti
increas
sensit
viral
diagnost
assay
allow
confirmatori
diagnos
agent
grow
standard
tissu
cultur
led
emerg
recognit
simultan
infect
multipl
viral
pathogen
occur
regularli
children
sought
determin
whether
virusviru
andor
virusbordetella
coinfect
frequent
sever
previous
recogn
sensit
polymeras
chain
reaction
pcr
assay
avail
detect
complet
set
pathogen
children
younger
month
hospit
febril
respiratori
ill
institut
octob
may
elig
enrol
studi
clinic
team
order
respiratori
viru
diagnost
test
sign
inform
consent
obtain
addit
nasopharyng
swab
specimen
collect
research
team
test
b
pertussi
b
parapertussi
institut
review
board
enrol
hospit
approv
studi
demograph
clinic
virolog
data
collect
hospit
record
includ
patient
age
gender
ethnic
underli
medic
condit
symptom
admiss
physic
exam
find
oxygen
requir
intens
care
unit
admiss
length
hospit
stay
enzymelink
immunoassay
eia
rsv
influenza
binax
rsv
influenza
b
test
kit
binax
inc
scarborough
bd
directigen
ez
rsv
ez
flu
b
kit
becton
dickinson
spark
md
respiratori
viral
cultur
perform
nasal
wash
andor
swab
collect
part
routin
clinic
evalu
dictat
clinic
team
octob
septemb
sampl
routin
clinic
care
collect
nasal
wash
eia
result
nasal
wash
specimen
neg
rsv
influenza
gener
respiratori
viral
cultur
perform
residu
nasal
wash
sampl
evalu
research
team
use
pcrbase
xtag
rvp
panel
luminex
corp
austin
tx
identifi
respiratori
virus
rsv
b
influenza
b
parainfluenza
human
metapneumoviru
rhinovirusenteroviru
adenoviru
coronavirus
clinic
virolog
laboratori
underw
oper
chang
begin
octob
respiratori
viral
cultur
nasal
wash
sampl
longer
perform
routin
instead
nasopharyng
flock
swab
copan
diagnost
corona
ca
submit
use
rvp
test
rvp
assay
perform
routin
patient
care
allow
detect
abovelist
respiratori
virus
test
coronavirus
includ
food
drug
administrationapprov
version
rvp
assay
result
still
avail
us
research
protocol
studi
purpos
anyal
posit
result
includ
viral
cultur
eia
rvp
consid
diagnost
second
nasal
swab
obtain
patient
process
detect
b
pertussi
b
parapertussi
dna
pcr
per
manufactur
protocol
diagenod
bordetella
real
time
pcr
diagenod
inc
sparta
nj
clinic
characterist
compar
use
student
test
total
children
enrol
studi
median
age
hospit
month
male
total
children
posit
viru
diagnost
test
tabl
total
patient
sampl
contain
singl
viru
contain
multipl
virus
overal
commonli
detect
virus
rsv
n
rhinovirusenteroviru
n
tabl
tabl
highlight
combin
viral
etiolog
document
children
dual
infect
instanc
multipathogen
infect
virus
detect
includ
simultan
detect
rsv
rhinovirusenteroviru
piv
one
sampl
simultan
detect
rsv
rhinovirusenteroviru
hmpv
common
clinic
diagnos
associ
children
enrol
studi
bronchiol
pneumonia
tabl
five
children
febril
respiratori
ill
also
diagnos
gastroenter
coronavirus
detect
sampl
patient
two
children
admit
primari
diagnosi
bronchiol
also
found
hepat
peak
serum
alt
ul
ul
dual
infect
document
patient
one
coronaviru
rsv
coronaviru
rhinovirusenteroviru
differ
patient
infect
one
viru
infect
multipl
pathogen
regard
oxygen
requir
intens
care
unit
admiss
length
hospit
stay
tabl
rapid
eia
test
rsv
perform
patient
sampl
eia
detect
rsv
sampl
wherea
pcr
identifi
rsv
sampl
viral
cultur
perform
posit
although
none
show
replic
one
viru
contrast
rvp
analysi
sampl
detect
nucleic
acid
one
agent
sampl
children
test
one
patient
test
posit
b
pertussi
one
b
parapertussi
patient
b
pertussi
coinfect
rsv
work
describ
etiolog
acut
febril
respiratori
ill
hospit
children
younger
month
use
diagnost
test
detect
virus
b
pertussi
b
parapertussi
detect
least
one
viru
enrol
children
histor
viru
detect
rate
describ
among
patient
studi
viral
etiolog
could
determin
diagnos
b
parapertussi
infect
remain
diagnos
clinic
bronchiol
andor
viral
syndrom
case
could
noninfecti
caus
atyp
bacteri
diseas
chlamydophila
pneumonia
chlamydia
trachomati
mycoplasma
pneumonia
unconfirm
pneumococc
infect
yet
identifi
viru
viru
normal
detect
rvp
sampl
test
issu
went
undetect
viru
detect
rvp
human
bocaviru
note
alland
et
al
describ
human
bocaviru
detect
children
hospit
acut
wheez
episod
overal
patient
simultan
infect
multipl
pathogen
coinfect
rate
within
publish
rang
six
patient
dualli
infect
virus
requir
differ
hospit
isol
procedur
specif
involv
coinfect
adenoviru
influenza
viru
requir
droplet
precaut
conflict
report
regard
multipathogen
viral
infect
associ
sever
acut
diseas
greensil
et
al
show
infant
sever
rsv
diseas
coinfect
hmpv
richard
et
al
found
infant
dual
infect
time
like
requir
pediatr
intens
care
unit
admiss
compar
singl
agent
infect
contrast
marguet
et
al
found
coinfect
rsv
rhinoviru
result
sever
diseas
hospit
infant
compar
infect
either
agent
alon
peng
et
al
found
differ
ill
sever
infect
caus
singl
multipl
virus
data
support
latter
conclus
found
differ
length
hospit
stay
likelihood
intens
care
unit
admiss
need
supplement
oxygen
among
hospit
infant
compar
infect
one
viru
infect
one
viru
sinc
hospit
enrol
criterion
studi
address
possibl
infect
one
viru
independ
risk
factor
lead
hospit
inclus
criteria
enrol
dictat
patient
studi
febril
respiratori
ill
nine
patient
also
promin
gastrointestin
complaint
gastroenter
hepat
gastroenter
diagnos
rhinovirusenteroviru
infect
n
adenoviru
infect
n
coronaviru
infect
coronaviru
coronaviru
patient
hepat
adenoviru
infect
dual
infect
coronaviru
either
rsv
rhinovirusenteroviru
although
unclear
whether
coronaviru
caus
contribut
hepat
either
case
interest
sever
anim
speci
coronavirus
primarili
tropic
gut
andor
liver
studi
period
global
pandem
caus
substanti
burden
health
care
system
result
pediatr
hospit
unit
state
alon
therefor
surpris
find
patient
influenza
infect
studi
group
sever
possibl
explan
observ
studi
melbourn
australia
found
major
influenzalik
ill
children
younger
year
influenza
pandem
actual
caus
rsv
infant
infect
influenza
viru
often
present
fever
sourc
lack
respiratori
symptom
altogeth
patient
would
elig
inclus
present
studi
although
distinguish
respiratori
infect
due
singl
viru
result
multipl
pathogen
may
chang
individu
patient
manag
chang
cohort
practic
hospit
isol
procedur
patient
hospit
rsv
rhinovirusenteroviru
hmpv
coronaviru
piv
infect
place
contact
precaut
contrast
patient
infect
adenoviru
influenza
b
pertussi
requir
droplet
precaut
unless
care
identifi
patient
coinfect
multipl
agent
may
unknowingli
use
improp
isol
cohort
procedur
frequenc
viru
coinfect
high
encourag
test
altern
respiratori
pathogen
even
viral
rapid
diagnosi
alreadi
establish
result
support
routin
test
screen
bordetella
infect
young
children
hospit
febril
respiratori
ill
clin
pediatr
phila
author
manuscript
avail
pmc
august
